Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

American Academy of Neurology Annual Meeting
Second International Porto Congress of Multiple Sclerosis
Immunology 2015
Webinar: "Seeking Best Practices in Classifier Construction and Testing"
“Veterinary Medicines” page
The Fourth International Conference on Regulatory T Cells and TH Subsets and Clinical Applications in Human Disease
Keystone Symposium: Viral Immunity
NYSCF Webinar Series: Multiple Sclerosis and the Promise of Stem Cell Research
Biogen Idec to acquire Fumapharm AG; Consolidates ownership of oral compound BG-12 being studied for multiple sclerosis
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Yes.
Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse.
T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion.
Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis.
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT.
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.
MS Frontiers 2015
Request for Applications for Collaborative Network Awards from the Progressive MS Alliance
ForuMS: A Virtual Journal Club for MS Clinicians
A phase 3 trial of extended release oral dalfampridine in multiple sclerosis.
Episode 18 with Dr. Samuel Ludwin on new approaches to remyelination therapies.
Meta-analysis of adverse events in recent randomized clinical trials for dimethil fumarate, glatiramer acetate and teriflunomide for the treatment of relapsing forms of multiple sclerosis.
Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis.
US and EU regulatory authorities accept oral BG-12 marketing applications for review
Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor kcyB (NF-kcyB) and Extracellular Signal-regulated kinase 1 and 2 (ERK1/2) and Mitogen Stress activated kinase 1 (MSK1) signaling.
Inhibition of LINGO-1 promotes functional recovery after experimental spinal cord demyelination.

Pages